Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis
Cells · 21.06.2023 · 12 (13) · 1672
DOI: 10.3390/cells12131672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 21.06.2023. Verfasst von Marcos A F Caetano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colitis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Support Foundation of the State of São Paulo, Higher Education Personnel Improvement Coordination, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
The enteric nervous system is affected by inflammatory bowel diseases (IBD). Gut microbiota ferments dietary fibers and produces short-chain fatty acids, such as Butyrate, which bind to G protein–coupled receptors, such as GPR41, and contribute to maintaining intestinal health. This work aimed to study the GPR41 in myenteric neurons and analyze the effect of Butyrate in mice submitted to experimental ulcerative colitis. The 2, 4, 6 trinitrobenzene sulfonic acid (TNBS) was injected intrarectally in C57BL/6 mice (Colitis). Sham group received ethanol (vehicle). One group was treated with 100 mg/kg of Sodium Butyrate (Butyrate), and the other groups received saline. Animals were euthanized 7 days after colitis induction. Analyzes demonstrated colocalization of GPR41 with neurons immunoreactive (-ir) to nNOS and ChAT-ir and absence of colocalization of the GPR41 with GFAP-ir glia. Quantitative results demonstrated losses of nNOS-ir, ChAT-ir, and GPR41-ir neurons in the Colitis group and Butyrate treatment attenuated neuronal loss. The number of GFAP-ir glia increased in the Colitis group, whereas Butyrate reduced the number of these cells. In addition, morphological alterations observed in the Colitis group were attenuated in the Butyrate group. The presence of GPR41 in myenteric neurons was identified, and the treatment with Butyrate attenuated the damage caused by experimental ulcerative colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
- Department of Surgery, School of Veterinary Medicine and Animal Sciences, University of São Paulo, São Paulo 05508-270, Brazil.
ORCID-Profile: Marcos A F Caetano, Henrique I R Magalhães
Förderung
- Research Support Foundation of the State of São Paulo
- Higher Education Personnel Improvement Coordination
- National Council for Scientific and Technological Development
- Programa Unificado de Bolsas (PUB/USP
Zitieren
APA
Caetano, M. A. F., Magalhães, H. I. R., Duarte, J. R. L., Conceição, L. B., & Castelucci, P. (2023). Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis. Cells, 12(13), 1672. https://doi.org/10.3390/cells12131672
Vancouver
Caetano MAF, Magalhães HIR, Duarte JRL, Conceição LB, Castelucci P. Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis. Cells. 2023;12(13):1672. doi:10.3390/cells12131672
BibTeX
@article{Caetano2023,
author = {Caetano, Marcos A F and Magalhães, Henrique I R and Duarte, Jheniffer R L and Conceição, Laura B and Castelucci, Patricia},
title = {Butyrate Protects Myenteric Neurons Loss in Mice Following Experimental Ulcerative Colitis},
journal = {Cells},
year = {2023},
volume = {12},
number = {13},
pages = {1672},
doi = {10.3390/cells12131672}
}
EUVIMED